contacts Sign In
image
author Image

Pfizer considers cost cuts as demand for COVID products falls

  • Home
  • Healthcare
  • Pfizer considers cost cuts as demand for COVID products falls
Pfizer said it anticipates more clarity on the future size of the COVID market later this year as infection rates rise in the autumn and the U.S. switches to a commercial market from government contracts for the vaccine.